The North Carolina Biotechnology Center awarded $100,000 to UNC Lineberger Comprehensive Cancer Center’s Chad Pecot, MD, to study an experimental treatment that would silence a gene commonly mutated in cancer. Using a Nobel Prize-winning technology called RNA interference or RNAi, Pecot’s lab designed an investigational drug to shut down the mutated version of the KRAS … Continued
Tag: Lung Cancer
The Lung Cancer Initiative of North Carolina has awarded $25,000 to Mark Woodcock, MD, to support a research effort to identify characteristics of lung cancer patients who will respond to treatments that unlock the immune system against cancer. Woodcock, a fellow in the UNC School of Medicine Division of Hematology/Oncology, was awarded a 2019-20 Lung … Continued
Researchers led by UNC Lineberger’s Chad Pecot, MD, report in the journal Nature Communications that for a particular subset of lung cancer tumors, there is a high prevalence of immune cells called inflammatory monocytes. These cells, which normally help to build clotting scaffolds to promote wound healing, also make it possible for tumor cells to migrate and spread to other parts of the body.